Numerous neuroprotective strategies assessed over the last decade

have failed in human trials, in part as a result of dose-limiting side

effects. In contrast, glibenclamide has been used safely in humans for

several decades for treatment of type 2 diabetes, with no untoward

side effects except hypoglycemia.

Products:

 NeuroBindi-Glib